SEC Form 4/A · accession 0001209191-16-137309
Spring Bank Pharmaceuticals, Inc. · SBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Nezam H. Afdhal
Officer — Chief Medical Officer
Period of report
Aug 10, 2016
Accepted (ET)
Aug 16, 2016 · 6:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001566373
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 10, 2016 | P | 1,600 | $10.8125 | A | 32,850 | D | |
| Common Stock | Aug 12, 2016 | P | 1,000 | $11.3184 | A | 33,850 | D |
Table II — derivative securities
No Table II lines on this filing.